126 related articles for article (PubMed ID: 7328842)
1. [Hyperglucagonemia in liver cirrhosis: relationship to hepatic dysfunction and portal systemic shunt (author's transl)].
Tsubouchi H; Kamibeppu A; Fujisaki K; Nagahama S; Kubosono O
Nihon Shokakibyo Gakkai Zasshi; 1981 Nov; 78(11):2193. PubMed ID: 7328842
[No Abstract] [Full Text] [Related]
2. Hyperglucagonemia in hepatic cirrhosis: its relation to hepatocellular dysfunction and normalization on recovery.
Kabadi UM; Eisenstein AB; Tucci J; Pellicone J
Am J Gastroenterol; 1984 Feb; 79(2):143-9. PubMed ID: 6364796
[TBL] [Abstract][Full Text] [Related]
3. [Hyperglucagonemia in patients with liver cirrhosis (author's transl)].
Tsubouchi H
Nihon Shokakibyo Gakkai Zasshi; 1982 Jan; 79(1):123. PubMed ID: 7098100
[No Abstract] [Full Text] [Related]
4. [Blood glucose and glucoregulatory hormones in liver cirrhosis: a study of 24 hour profiles and of the role of portal-systemic shunting].
Marchesini G; Zoli M; Dondi C; Angiolini A; Forlani G; Melli A; Bianchi FB; Pisi E
Gastroenterol Clin Biol; 1982 Mar; 6(3):272-8. PubMed ID: 7047286
[No Abstract] [Full Text] [Related]
5. Hyperglucagonemia in Laennec's cirrhosis. The role of portal-systemic shunting.
Sherwin R; Joshi P; Hendler R; Felig P; Conn HO
N Engl J Med; 1974 Jan; 290(5):239-42. PubMed ID: 4808927
[No Abstract] [Full Text] [Related]
6. Hyperglucagonemia in cirrhosis: altered secretion and sensitivity to glucagon.
Sherwin RS; Fisher M; Bessoff J; Snyder N; Hendler R; Conn HO; Felig P
Gastroenterology; 1978 Jun; 74(6):1224-8. PubMed ID: 648812
[TBL] [Abstract][Full Text] [Related]
7. Glucagon metabolism in normal subjects and in cirrhotic patients before and after portasystemic venous shunt surgery.
Alford FP; Dudley FJ; Chisholm DJ; Findlay DM
Clin Endocrinol (Oxf); 1979 Oct; 11(4):413-24. PubMed ID: 519879
[TBL] [Abstract][Full Text] [Related]
8. [Are disturbances of small intestinal motility associated with hyperglucagonemia in patients with liver cirrhosis?].
Chesta J; Generini G; Antezana C; Defilippi C
Rev Med Chil; 1992 Sep; 120(9):998-1002. PubMed ID: 1340993
[TBL] [Abstract][Full Text] [Related]
9. Effect of transjugular intrahepatic portosystemic shunt on glycometabolism in cirrhosis patients.
Su AP; Cao SS; Le Tian B; Da Zhang Z; Hu WM; Zhang Y; Wang ZL; Babu SR; Hu T
Clin Res Hepatol Gastroenterol; 2012 Feb; 36(1):53-9. PubMed ID: 22099870
[TBL] [Abstract][Full Text] [Related]
10. [Angiographic control of portocaval anastomoses. A study of hepato-portal circulatory changes after shunt (author's transl)].
Possati L; Cavallari A; Mazziotti A; Antonini L; Roversi RA; Rossi C
J Radiol; 1981; 62(6-7):351-61. PubMed ID: 7288733
[TBL] [Abstract][Full Text] [Related]
11. Carbohydrate and lipid metabolism in cirrhosis. Evidence that hepatic uptake of gluconeogenic precursors and of free fatty acids depends on effective hepatic flow.
Nosadini R; Avogaro A; Mollo F; Marescotti C; Tiengo A; Duner E; Merkel C; Gatta A; Zuin R; de Kreutzenberg S
J Clin Endocrinol Metab; 1984 Jun; 58(6):1125-32. PubMed ID: 6373811
[TBL] [Abstract][Full Text] [Related]
12. Effect of portasystemic venous shunt surgery on hyperglucagonaemia in cirrhosis: paired studies of pre- and post-shunted subjects.
Dudley FJ; Alford FP; Chisholm DJ; Findlay DM
Gut; 1979 Oct; 20(10):817-24. PubMed ID: 533693
[TBL] [Abstract][Full Text] [Related]
13. [Effect of distal splenocaval shunt on splanchnic hemodynamics in patients with liver cirrhosis and portal hypertension].
Cai JX
Zhonghua Wai Ke Za Zhi; 1991 Jul; 29(7):426-8, 462. PubMed ID: 1813226
[TBL] [Abstract][Full Text] [Related]
14. Functional hepatic flow can predict the hepatic reserve function in surgical cirrhotic patients.
Xingjiang W; Weiwei D; Jianmin C; Jianming H; Jieshou L
J Invest Surg; 2009; 22(3):178-82. PubMed ID: 19466654
[TBL] [Abstract][Full Text] [Related]
15. Central nervous system alterations in liver cirrhosis: the role of portal-systemic shunt and portal hypoperfusion.
Del Piccolo F; Sacerdoti D; Amodio P; Bombonato G; Bolognesi M; Mapelli D; Gatta A
Metab Brain Dis; 2002 Dec; 17(4):347-58. PubMed ID: 12602511
[TBL] [Abstract][Full Text] [Related]
16. Central nervous system alterations in liver cirrhosis: the role of portal-systemic shunt and portal hypoperfusion.
Del Piccolo F; Sacerdoti D; Amodio P; Bombonato G; Bolognesi M; Mapelli D; Gatta A
Metab Brain Dis; 2003 Mar; 18(1):51-62. PubMed ID: 12603082
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of glucagon secretion by gastric inhibitory polypeptide in patients with hepatic cirrhosis and hyperglucagonemia.
Dupre J; Caussignac Y; McDonald TJ; Van Vliet S
J Clin Endocrinol Metab; 1991 Jan; 72(1):125-9. PubMed ID: 1986010
[TBL] [Abstract][Full Text] [Related]
18. A method of measuring quantitative hepatic function and hemodynamics in cirrhosis: the changes following distal splenorenal shunt.
Henderson JM; Warren WD
Jpn J Surg; 1986 May; 16(3):157-68. PubMed ID: 3488457
[TBL] [Abstract][Full Text] [Related]
19. [Hepatic blood flow, portal hypertension and liver failure in patients with alcoholic cirrhosis (author's transl)].
Lebrec D; Sicot C; Benhamou JP
Arch Fr Mal App Dig; 1973 Sep; 62(6):465-71. PubMed ID: 4779228
[No Abstract] [Full Text] [Related]
20. ["3" pattern spleno-renal shunt (author's transl)].
Wang XE
Zhonghua Wai Ke Za Zhi; 1979; 17(6):496-7. PubMed ID: 556052
[No Abstract] [Full Text] [Related]
[Next] [New Search]
